LDL-C reduction with lerodalcibep in patients at very high or high risk for CVD: The phase 3 LIBerate-HR study

Triglyceride reduction with olezarsen in HTG patients with high CV risk: The BRIDGE-TIMI 73a trial

Weight and HF outcomes in obese HFpEF and T2DM patients with semaglutide in the STEP-HFpEF DM trial

“Inclisiran first” strategy lowers LDL-C in real-world ASCVD patients: Results from the VICTORION-INITIATE trial

Ticagrelor monotherapy after 1 month of DAPT outperforms 12-month DAPT post-PCI in reducing bleeding events in ACS patients: The ULTIMATE-DAPT trial

Mandibular advancement device shows similar effectiveness as CPAP in reducing BP in OSA patients